U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

The FDA Drug Shortage database is currently experiencing technical difficulties and some of the information contained in the database may not reflect the current supply status.

Start Over | Back to Previous Screen

Daptomycin Injection
Status: Discontinuation
»Therapeutic Categories: Anti-Infective

Expand all

Fresenius Kabi USA, LLC (New 05/17/2022)

Company Contact Information:
888-386-1300

Presentation Posting Date Related Information
350mg (NDC 63323-585-15) N/A
500mg (NDCs 63323-371-10, 63323-371-19, and 63323-871-15) N/A

Merck Sharp & Dohme Corp. (New 10/08/2021)

Company Contact Information:
800-672-6372

Presentation Posting Date Related Information
500 mg (NDC 67919-011-01) N/A

Merck Sharp & Dohme Corp., a subsidiary of Merck and Co., Inc. (New 08/02/2022)

Company Contact Information:
800-672-6372

Presentation Posting Date Related Information
500 mg (NDC 67919-012-01) 08/02/2022

Pfizer (New 07/26/2022)

Company Contact Information:
844-646-4398

Presentation Posting Date Related Information
350 mg lyophilized; 15 mL Single-dose vial (NDC 0409-5933-01) 07/26/2022 Supply expected to exhaust 01Sep2022; Replaced with NDC 0409-0120-01; Discontinuation of the manufacture of the drug.
500 mg lyophilized; 15 mL Single-dose vial (NDC 0409-2757-01) 07/26/2022 Supply expected to exhaust 01Oct2022; Replaced with NDC 0409-0122-01; Discontinuation of the manufacture of the drug.
Back to Top